Cogni Pharmaceuticals Private Limited
About Cogni Pharmaceuticals Private Limited
Data last updated:
Cogni Pharmaceuticals Private Limited was a private limited company based in Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 May 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC177516.
The company had an authorised share capital of ₹40 Lakh and a paid-up capital of ₹24.89 Lakh. It was led by directors Ashutosh Goel and Mayank Goel.
Its last annual general meeting (AGM) was held on 23 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office was at A – 4 Third Floor Pushpanjali Enclave, Pitampura New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹59.22 Lakh, a growth of 115% compared to the previous year. For the same year it recorded a net profit of ₹15.04 Lakh (net margin 25.4%) and EBITDA of ₹23.07 Lakh (EBITDA margin 39%). Revenue has grown at a compounded annual rate (CAGR) of 58% over three years and 43% over five years.
Company details
Contact details
Cogni Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 4 Third Floor Pushpanjali Enclave, Pitampura New Delhi, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cogni Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Cogni Pharmaceuticals Private Limited
FY 2026 filings availableCogni Pharmaceuticals Private Limited reported revenue of ₹59.22 Lakh (up 115% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 43% over five years, including 115% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 39% | ||||
| Net Profit Margin | 25.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cogni Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cogni Pharmaceuticals Private Limited
Cogni Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Goel | Additional Director | 20 Jun 2026 | 0 Years 4 Months | As last reported |
| Mayank Goel | Additional Director | 20 Jun 2026 | 0 Years 4 Months | As last reported |
Peer comparison
Cogni Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cogni Pharmaceuticals Private Limitedthis company | ₹59.22 Lakh (FY 2026) | ₹15.04 Lakh | 25.4% | 115.0% | Delhi, India | |
| Ambrosia Drugs Private Limited | ₹27.67 Lakh (FY 2025) | -87.0% | Haridwar, Uttarakhand, India | |||
| Samvee Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2022) | 5.0% | Hyderabad, Telangana, India | |||
| Ceedar Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2025) | -14.0% | Kanpur, Uttar Pradesh, India | |||
| Fervour Pharmaneutics Private Limited | ₹27.62 Lakh (FY 2024) | 11.0% | New Delhi, Delhi, India | |||
| Happypill Healthcare (OPC) Private Limited | ₹27.61 Lakh (FY 2025) | 49.0% | Pune, Maharashtra, India | |||
| Bluedrop Retails Private Limited | ₹27.6 Lakh (FY 2022) | 198.0% | Anand, Gujarat, India | |||
| Suniris Enterprises OPC Private Limited | ₹27.6 Lakh (FY 2019) | 1009.0% | Bhatinda, Punjab, India | |||
| Schavan Pharmaceuticals Private Limited | ₹27.59 Lakh (FY 2019) | 77.0% | Kozhikode, Kerala, India | |||
| Myelin Lifesciences Private Limited | ₹27.59 Lakh (FY 2025) | 590.0% | Lucknow, Uttar Pradesh, India | |||
| Himanshu Pharmaceuticals Private Limited | ₹27.58 Lakh (FY 2024) | -76.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Cogni Pharmaceuticals Private Limited, buy the company report.
Auditor
Cogni Pharmaceuticals Private Limited is audited by J D A & COMPANY for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J D A & COMPANY | FY 2018 | 015377N |
Shareholding
The shareholding of Cogni Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Cogni Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cogni Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cogni Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cogni Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cogni Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Ashutosh Goel was appointed as Additional Director on 20 Jun 2026.
Frequently asked questions
Cogni Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Cogni Pharmaceuticals was a private limited company based in Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 May 2008 and is registered under CIN U24232DL2008PTC177516. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Cogni Pharmaceuticals is U24232DL2008PTC177516. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cogni Pharmaceuticals had 2 directors:
- Ashutosh Goel - Additional Director
- Mayank Goel - Additional Director
Cogni Pharmaceuticals was incorporated on 01 May 2008. It is registered with the Registrar of Companies, Delhi.
The registered office of Cogni Pharmaceuticals is at A – 4 Third Floor Pushpanjali Enclave, Pitampura New Delhi, Delhi, India – 110034.
The latest financial statements of Cogni Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 23 May 2026. Year-wise statements from 2015 are in the company report.
Cogni Pharmaceuticals operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Cogni Pharmaceuticals by revenue are Ambrosia Drugs Private Limited, Samvee Pharmaceuticals Private Limited, Ceedar Pharmaceuticals Private Limited, Fervour Pharmaneutics Private Limited, Happypill Healthcare (OPC) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Ashutosh Goel was appointed as Additional Director on 20 Jun 2026. Mayank Goel was appointed as Additional Director on 20 Jun 2026. Amit Singla ceased to be Additional Director on 25 Sep 2019. Cogni Pharmaceuticals has 4 board changes on record in total.
The compliance status of Cogni Pharmaceuticals is compliant as of 01 November 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
